CAS 115334-05-9: Lanost-7-ene-3,23-diol,24,25-epoxy-, (3b,13a,14b,17a,20S,23R,24S)-

Dihydroniloticin is a naturally occurring diterpenoid, which is an organic compound derived from certain plant species, particularly those in the family Guttiferae. This compound is isolated through extraction from the plant’s bark, leaves, or seeds. The mode of action of dihydroniloticin is primarily centered on its ability to interfere with cellular processes, which may include the inhibition of certain enzymes and regulatory pathways that are crucial for cell division and growth. This makes it a candidate for antitumor activity, as it may induce apoptosis or other forms of programmed cell death in cancerous cells. The primary uses and applications of dihydroniloticin are in the field of medicinal research, particularly in exploring novel anticancer therapies. Scientists are investigating its potential therapeutic efficacy and safety profiles through in vitro and in vivo studies. Moreover, its unique chemical structure is of interest for synthetic modifications that could enhance its biological activities or reduce any potential side effects.

Dihydroniloticin shows cytotoxic activity against a HT-1080 human fibrosarcoma cell line( IC50 = 8.2 microM).